How clinical development can, and should, inform translational science

Area of Science:

• Translational medicine
• Neuroscience
• Clinical trial design

Background:

• Significant need for effective therapies for central nervous system (CNS) disorders.
• Many promising preclinical treatments fail to translate into successful clinical therapies.
• Current translational efforts lack sufficient clinical integration.

Purpose of the Study:

• To propose a strategic framework for enhancing preclinical to clinical translation.
• To identify key factors for successful clinical trial initiation and execution.
• To improve the likelihood of therapeutic success for CNS conditions.

Main Methods:

• Perspective piece based on expert opinion and review of translational challenges.
• Focus on early collaboration between preclinical and clinical scientists.
• Identification of critical elements for clinical trial planning.

Main Results:

• Early partnership facilitates proactive planning of clinical trial parameters.
• Consideration of patient populations, dosing, timing, duration, and biomarkers is crucial.
• Addressing practical trial aspects enhances project viability for investment and success.

Conclusions:

• Integrating clinical insights early in preclinical development is essential for therapeutic breakthroughs.
• Strategic planning of clinical trials increases the probability of successful translation.
• Enhanced collaboration can accelerate the delivery of novel CNS therapies to patients.